Israel Englander’s Cantel Medical Corporation CMD Stock Holding History

Israel Englander’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-5,000	Closed	-$394K	–	6812
2020 Q4	$394K	Sell	5,000 -5,000	-50%	-$293K	﹤0.01%	4383
2020 Q3	$439	Buy	+10,000	New	+$493K	﹤0.01%	3645
2020 Q1	–	Sell	-7,000	Closed	-$496K	–	4794
2019 Q4	$496K	Buy	7,000 +2,000	+40%	+$145K	﹤0.01%	3388
2019 Q3	$374K	Sell	5,000 -5,000	-50%	-$424K	﹤0.01%	3443
2019 Q2	$806K	Hold	10,000	–	–	﹤0.01%	2932
2019 Q1	$669K	Hold	10,000	–	–	﹤0.01%	3093
2018 Q4	$745K	Sell	10,000 -5,000	-33%	-$413K	﹤0.01%	2735
2018 Q3	$1.38M	Buy	+15,000	New	+$1.43M	﹤0.01%	2681

Israel Englander's CMD Position: Q2 2021 in Review

Israel Englander sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 117,941 shares — an estimated $9.42M sold.

Israel Englander first reported a position in CMD in Q2 2013 and held it in 23 quarters. The position peaked at $25.8M in Q2 2018. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.

Israel Englander reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
Israel Englander sold 117,941 Cantel Medical Corporation shares in Q2 2021, an estimated $9.42M.
Israel Englander first reported a position in Cantel Medical Corporation in Q2 2013 and held it in 23 quarters.
Israel Englander's Cantel Medical Corporation position peaked at $25.8M in Q2 2018.
0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.

Based on Millennium Management's 13F filing for Q2 2021, filed 16 Aug 2021.